ProQR Therapeutics N.V.
PRQR
$2.27
$0.010.44%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -85.44% | -11.00% | 1.17% | 31.65% | 57.86% |
| Total Depreciation and Amortization | -1.55% | 2.48% | 9.90% | 13.23% | 14.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 213.98% | 173.92% | 205.25% | -160.10% | -136.00% |
| Change in Net Operating Assets | 47.18% | 16.68% | -127.34% | -125.48% | -129.34% |
| Cash from Operations | -23.44% | 4.93% | -272.57% | -440.61% | -1,335.94% |
| Capital Expenditure | 61.58% | 54.06% | -3.73% | -148.87% | -199.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -75.22% | -75.22% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 227.51% | 227.51% | -143.14% | -- | -- |
| Cash from Investing | 203.65% | 202.23% | -189.90% | 651.75% | -2,155.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 39.68% | 46.87% | 39.83% | -54.39% | 94.23% |
| Issuance of Common Stock | 13,592.94% | 13,807.56% | 20,198.87% | -97.38% | -96.29% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3,438.93% | 2,937.96% | 3,145.25% | -119.03% | 92.78% |
| Foreign Exchange rate Adjustments | -2,188.81% | -84.68% | 8.58% | 63.45% | -98.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 180.31% | 186.90% | 25.49% | -255.76% | -105.98% |